Development of Cancer Therapy-Related Cardiac Dysfunction Is Associated With Disease Progression in Breast Cancer.

Although the associations did not reach statistical significance, the hazard ratios in these subgroup analyses remained in the same direction as in the overall cohort in the anthracycline-based regimen group (HR 1.91; 95% CI 0.67–4.99; P=0.215; Supplementary Table ) and in the anthracycline plus anti-HER2-based regimen group (HR 7.45; 95% CI 0.89–62.12; P=0.062; Supplementary Table ).

also in 111,027 other papers